Loading
Topic
CETP Inhibitors
Last discussed
3y ago
May 22, 2023
0 tagged in 12 months
255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia
The Peter Attia Drive·May 22, 2023
All time
1
episodes
On record
1
took a position
Where they standWhere they stand
Talking pointsNot enough disagreement in the transcripts to form camps. These are the positions taken by people with demonstrated expertise on this topic first, then by how many people heard them on it, then by VoiceRank. Positions are extracted from transcripts by a model and may misattribute who said what. Every quote links to the episode it came from.
JK
CETP inhibitors have the potential to treat cardiovascular disease and conditions like Alzheimer's by altering lipoprotein metabolism.
“however John makes a pretty compelling case for the most recent version of these drugs to be not only a potential Game Changer a word that I hate for cardiovascular disease but perhaps even more interestingly for Alzheimer's disease and type 2 diabetes”
The Peter Attia Drive · May 2023 · 1 episode · 30K views on this topicExtracted by a model; may misattribute who said what.
In the transcripts